JPH02240093A - Production of glycoside-based compound of ketose - Google Patents

Production of glycoside-based compound of ketose

Info

Publication number
JPH02240093A
JPH02240093A JP6015089A JP6015089A JPH02240093A JP H02240093 A JPH02240093 A JP H02240093A JP 6015089 A JP6015089 A JP 6015089A JP 6015089 A JP6015089 A JP 6015089A JP H02240093 A JPH02240093 A JP H02240093A
Authority
JP
Japan
Prior art keywords
ketose
trityl
acid ester
derivatives
mmol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP6015089A
Other languages
Japanese (ja)
Other versions
JPH0653754B2 (en
Inventor
Toshiyuki Inazu
敏行 稲津
Takashi Yamanoi
孝 山ノ井
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Noguchi Institute
Original Assignee
Noguchi Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Noguchi Institute filed Critical Noguchi Institute
Priority to JP6015089A priority Critical patent/JPH0653754B2/en
Publication of JPH02240093A publication Critical patent/JPH02240093A/en
Publication of JPH0653754B2 publication Critical patent/JPH0653754B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

PURPOSE:To industrially obtain the subject compound useful as a carcinostatic agent, sweetener, etc., in good yield by reacting a thiophosphinic acid ester derivative of a ketose at the anomeric position with a specific alcohol in the presence of a trityl salt. CONSTITUTION:A thiophosphinic acid ester derivative at the anomeric position of a ketose in which hydrogen of hydroxyl group in a saccharide having the anomeric position of the ketose is bound through ketal linkage is substituted with phosphinothioyl group expressed by the formula (R<1> and R<2> are alkyl or aryl) is reacted with an alcohol selected from aliphatic alcohols, aromatic alcohols, steroid alcohols, glycerol derivatives, saccharide derivatives and amino acid derivatives in a molar equiv. amount of 1 to several times, 3-200mol% trityl salt (e.g. trityl perchlorate) as an activator and a dehydrating agent (e.g. molecular sieves) in a solvent, such as ethanol, at -40 to -60 deg.C to afford the objective compound.

Description

【発明の詳細な説明】 本発明はケトースのアノメリック位チオホスフィン酸エ
ステル誘導体とアルコールを反応させ、グリコシド系化
合物を製造する方法に関するものである.ケトースのグ
リコシド系化合物は制ガン剤、毒素中和剤、神経細胞生
長剤、甘味科等として医薬、農薬などの用途に注目をあ
びているが、その合成には不安定な中間体を使用し、工
業的に優れた方法は未だ知られていない. 従来知られている方法はハロゲノケトースとアルコー・
ルな反応させるが、原料のハロゲノケ}一スの安定性が
乏しいこと、高度に脱水しk反応条件が必要なこと等欠
点が多く工業化は困難である.本発明者は上記の事情に
鑑み鋭意研究した結果、ケトースのアノメリツク位チオ
ホスフィン酸エステル誘導体を用い、 トリチル塩を活
性化剤として使用することで目的を達しうることを知り
本発明に到達した. 以下、本発明について詳細に説明する.本発明の原料の
1つ、ケトースのアノメリツク位子オホスフィン酸エス
テル誘導体は、アノメリック位の水酸基が遊離のケトー
スとハロゲン化ホスフィノチオイルと塩基存在下合成で
きる.ケトースは周知のものを使用できる.具体的には
トアセチルノイラミン酸、3−デオキシ−2一オクツロ
ソン酸、フルクトース等天然型のもの、あるいは、合成
によりC−1位の水素をアルキル基、アリール基、カル
ボキシル基、二トリル基等で置換された非天然型ケトー
スなどを挙げることかでき る. ハロゲン化ホスフィノチオイルとしては周知のものを使
用できる.例えば塩化ジメチルホスフイノチオイル、臭
化ジメチルホスフィノチオイル、塩化ジフエニルホスフ
ィノチオイル等が挙げられる. 塩基としては周知のものを使用できる。例えば水酸化ナ
トリウム、 トリエチルアミン、 1,8ージアザビシ
クロ[5.4.0コウンデカ−7−エン、 n −ブチ
ルリチウム等を挙げることができる。本発明の池の原料
の1つとして使用されるアルコールは周知のものを使用
できる,例えば脂肪族アルコール、芳香旅アルコール、
ステロイドアルコール、グリセロール誘導体、糖誘導体
、アミノ酸誘導体が挙げられる.具体的にはメタノール
、エタノール、オクチルアルコール、フェノール、ベン
ジルアルコール、 1、 2、 3、4−ジイソプロビ
リデンガラクトース、 3β−コレスタノール、 イソ
ブロビリデングリセロール、N−ペンジルオキシカルポ
ニルーし−セリンメチルエステルなどの一例が挙げられ
る. 続いてケトースのアノメリック位チオホスフィン酸エス
テルと前述したアルコールとの反応について説明する,
この方法ではこれらのモル比は特に制限はなくアルコー
ルを大過剰に用いてもよいが、通常は1〜数倍モル等量
である. 溶媒はアルコールを除く周知の有機溶媒を使用で吉る.
例えばエーテル、ベンゼン、 トルエン、ジクロロメタ
ン等を挙げることができる.反応温度は特に制限はない
が、−40℃〜60℃好ましくは−20℃〜40℃であ
る.反応時間は反応温度、原料の種類等によってことな
るが、数分〜数十時閏の範囲である. 反応を行うにあたってはケトースのアノメリック位チオ
ホスフィン酸エステル誘導体に対し、周知のトリチル塩
の共存下で行う。 トリチル塩は3〜200モル%で行
うこともできるが、好ましくは5〜50モル%で使用す
る.周知のトリチル塩としては過塩素酸トリチル、過塩
素酸p−メトシキフエニルジフエニルメチル、ペンタク
ロルスズ酸トリチル、ヘキサク口aアンチモン酸トリチ
ル、テトラフルオ口ホウ酸トリテル等を挙げることがで
きる。これらの活性剤となる塩は特に無水状態にするこ
どもなく反応系にモIノキュラーシーブス等の脱水剤を
共存させるだけで十分である。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a method for producing a glycoside compound by reacting an anomeric thiophosphinate derivative of ketose with an alcohol. Ketose glycoside compounds are attracting attention for use in medicines and agricultural chemicals as anticancer agents, toxin neutralizers, nerve cell growth agents, sweeteners, etc., but their synthesis requires unstable intermediates and industrial No good method is known yet. The conventionally known method is to use halogenoketose and alcohol.
However, it has many drawbacks such as poor stability of the raw material halogen oxide and the need for highly dehydrated reaction conditions, making it difficult to industrialize. As a result of extensive research in view of the above circumstances, the present inventors discovered that the objective could be achieved by using an anomeric thiophosphinic acid ester derivative of ketose and a trityl salt as an activator, and arrived at the present invention. The present invention will be explained in detail below. One of the raw materials of the present invention, an anomeric ophosphinic acid ester derivative of ketose, can be synthesized from a ketose with a free anomeric hydroxyl group and a halogenated phosphinothioyl in the presence of a base. Any known ketose can be used. Specifically, natural types such as toacetylneuraminic acid, 3-deoxy-2-octulosonic acid, and fructose, or synthetically substituted hydrogen at the C-1 position with an alkyl group, aryl group, carboxyl group, nitrile group, etc. Examples include non-natural ketoses substituted with Well-known halogenated phosphinothioyls can be used. Examples include dimethylphosphinothioyl chloride, dimethylphosphinothioyl bromide, diphenylphosphinothioyl chloride, and the like. As the base, well-known bases can be used. Examples include sodium hydroxide, triethylamine, 1,8-diazabicyclo[5.4.0 condec-7-ene, n-butyllithium, and the like. As the alcohol used as one of the raw materials for the pond of the present invention, well-known alcohols can be used, such as aliphatic alcohols, aromatic alcohols,
Examples include steroid alcohols, glycerol derivatives, sugar derivatives, and amino acid derivatives. Specifically, methanol, ethanol, octyl alcohol, phenol, benzyl alcohol, 1, 2, 3, 4-diisopropylidene galactose, 3β-cholestanol, isobropylidene glycerol, N-penzyloxycarponyl-serine An example is methyl ester. Next, we will explain the reaction between the anomeric thiophosphinic acid ester of ketose and the aforementioned alcohol.
In this method, there is no particular restriction on the molar ratio of these alcohols, and a large excess of alcohol may be used, but it is usually one to several times the molar equivalent. It is best to use a well-known organic solvent other than alcohol as the solvent.
Examples include ether, benzene, toluene, dichloromethane, etc. The reaction temperature is not particularly limited, but is between -40°C and 60°C, preferably between -20°C and 40°C. The reaction time varies depending on the reaction temperature, type of raw materials, etc., but ranges from several minutes to several tens of hours. The reaction is carried out on the anomeric thiophosphinic acid ester derivative of ketose in the presence of a well-known trityl salt. The trityl salt can be used in an amount of 3 to 200 mol%, but is preferably used in an amount of 5 to 50 mol%. Examples of well-known trityl salts include trityl perchlorate, p-methoxyphenyldiphenylmethyl perchlorate, trityl pentachlorostannate, trityl hexachloroantimonate, trityl tetrafluoroborate, and the like. These salts serving as activators need not be brought into an anhydrous state, and it is sufficient to simply coexist a dehydrating agent such as monocular sieves in the reaction system.

本発明はこのように有用な化合物を収率良く、緩和な条
件下で製造でき、副生成物も少なく、その工業的価値は
大である. 以下に実施例を挙げて本発明を具体的に説明するが本発
明はその要旨を越えない限り、以下の実施例により何等
の制限もうけるものではない。
As described above, the present invention enables the production of useful compounds in good yields under mild conditions, produces few by-products, and has great industrial value. EXAMPLES The present invention will be specifically explained below with reference to examples, but the present invention is not limited in any way by the following examples unless the gist of the invention is exceeded.

参考例1 34  2 〜 3.1(m+ 15H), 7. 0 〜 7。Reference example 1 34 2 ~ 3.1 (m+ 15H), 7. 0 ~ 7.

4(s.20  打) 1,  3,  4.  5−テトラーO−ベンジルー
D−アラビノー2−へキツロビラノース220mmg(
0.41mmol)をTHF2mlに溶解し、水冷下1
.l5Mのヘキサン溶液としたブチルリチウム0.3m
l (0.45mmo!)を加え、 15分攪はんし塩
化ジメチルホスフイノチオイル63mg(0.  49
mmol)をTHF 1m+に溶解して加える.2時間
O℃で攪はんし、水を加えてジクロ口メタンで抽出し、
有機層を無水lilt酸ナトリウムで乾燥した後、溶媒
を減圧留去し調製用シリカゲル薄層クロマトく屓閏剤;
 ヘキサン: 詐酸エチル=4:1)で精製して1, 
 3,  4.  5−テトラー0−ベンジルーD−ア
ラビノー2−へキツロビラノシルジメチルホスフイノチ
オエート204mg (79%)が得られた. H−NMR;   1.6〜2.  0 (d,  6
}!).参考例2 参考例1の 1.  3,  4.  5−テトラー0
−ベンジルーD−アラビノー2−へキッロビラノースの
代わりにグルコースのC−1位の水素がメチル基で置換
された3,  4,  3.  7−テトラー0−ベン
ジルー1−デオキシーD−グルコー2−ヘブッロビラノ
ース4f2mg(0.74mmol)を用い同様の反応
を行い3,  4.  5.  7−テトラーO−ベン
ジル−1−デオキシーD−グルコー2−ヘブツロビラノ
シルジメチルホスフィノチオエー}200mg  (4
2  % ) を得 る.IH−NMR;   1.7
〜2.  1 (t,  9H).3.  5 〜5.
  1(m,  14H),   7.  0 〜7.
5(m,20H) 参考例3 参考例1の1.  3,  4.  5−テトラー0−
ベンジルーD−アラビノー2−へキツロビラノースの代
わりにグルコースのC−1位の水素がエチル基で置換さ
れた4,  5,  6.  8−テトラー0−ベンジ
ルー1.  2−ジデオキシーD一エリスコーDーグル
コー3−オクツロビラノース295mg(0.52mm
o+)を用い同様の反応を行い4,5,6.8−テトラ
ーO−ベンジル−1,2−ジデオキシ−D一エリスロー
D−グルコー3−オクツロビラノシルジメチルホスフィ
ノチオエート93mg(27%)を得る. ’H−NMR;   0.7〜1.  1 (t,  
3H),1.  6 〜2.  1 (m,  6H)
,   2.  2 〜2.  7(m,  2H),
   3.  吐づ.2(m,  14H),?.  
s 〜7.  5(m.  20H)′#考例1で合成
したジメチルホスフィノチオエート化合物204mg 
(0.  32mmo l)、3C−コレスタノール1
 26mg (0.32mmo1〉、過塩業酸トリチル
llmg(0.032mmol)、モレキュラーシーブ
ス粉末をベンゼンlmlに懸一濁させ、30分間室温で
攪はんし飽和、炭酸水素ナトリウム水溶液5 m lを
加え反応を俸止する.反応混合物をろ過後ジクロ口メタ
ンで抽出し、有機層を無水Fare!Iナトリウムで乾
燥して、溶媒を減圧留去し調製用シリカゲル薄層クロマ
ト(Jilm剤; ヘキサン: 酢酸エチル=4:1)
で精製したところ目的のグリコシル化合物が167mg
(57%)得られた. ’H−NMR;    0.  2 〜2.  2 (
m,  46H),3.  CL〜5.  1(m. 
 16H),   7.  0 〜7、6(m,20H
) 実施例2 参考例2で合成したジメチルホスフィノチオエート化合
物97mg (0.  1 15mmo l)、3Q一
ニレスタノール58mg(0.  15mmol)、過
塩素酸トリチル5mg(0.  01!5mmol)、
モレキュラーシーブス粉末をベンゼンlmlに懸濁させ
、30分間室温で攪はんし飽和炭酸水素ナ実施例3 参考例2で合成したジメチルホスフィノチオエート化合
*78mg(0.  12mmol).3fi’−プレ
スタノール47mg (0.  1 2mmo l)+
過塩素酸トリチル2.3mg(0.006mmol),
モレキュラーシーブス粉末をベンゼン1mlに懸濁させ
、30分閘室温で攪はんし飽和炭酸水素ナトリウム水溶
液5mlを加え反応を停止する。以後実施例1と同様の
処理を行いグリコシル化合物79mg (7 1%)を
得た.’H−NMRは実施例2に同じ。
4 (s.20 strokes) 1, 3, 4. 5-Tetra O-benzyru-D-arabino 2-hekituroviranose 220 mmg (
0.41 mmol) was dissolved in 2 ml of THF, and cooled with water for 1 hour.
.. 0.3m of butyl lithium in 15M hexane solution
1 (0.45 mmo!) and stirred for 15 minutes.
mmol) in THF 1m+ and add. Stir at 0°C for 2 hours, add water and extract with dichloromethane.
After drying the organic layer with anhydrous sodium lyltate, the solvent was distilled off under reduced pressure to prepare a silica gel thin layer chromatography reagent;
Purify with hexane: ethyl sulfate = 4:1) to 1,
3, 4. 204 mg (79%) of 5-tetra 0-benzy-D-arabino 2-hekituroviranosyldimethylphosphinothioate was obtained. H-NMR; 1.6-2. 0 (d, 6
}! ). Reference example 2 Reference example 1 1. 3, 4. 5-Tetler 0
3, 4, 3. Hydrogen at the C-1 position of glucose is substituted with a methyl group instead of -benzyl-D-arabino-2-hekilovyranose. A similar reaction was carried out using 2 mg (0.74 mmol) of 7-tetra 0-benzy-1-deoxy-D-glucose 2-hebroviranose 3, 4. 5. 7-tetra O-benzyl-1-deoxy-D-glucose 2-hebuturoviranosyldimethylphosphinothioate} 200 mg (4
2%). IH-NMR; 1.7
~2. 1 (t, 9H). 3. 5 ~5.
1 (m, 14H), 7. 0 to 7.
5 (m, 20H) Reference Example 3 1 of Reference Example 1. 3, 4. 5-Tetler 0-
4, 5, 6. Hydrogen at the C-1 position of glucose is substituted with an ethyl group instead of benzy-D-arabino-2-hekituropyranose. 8-tetler 0-benzyru 1. 2-Dideoxy-D-Elisco D-Gluco 3-Octuroviranose 295mg (0.52mm
4,5,6.8-Tetra O-benzyl-1,2-dideoxy-D-erythro D-glucose 3-octulobyranosyldimethylphosphinothioate 93 mg (27%) obtain. 'H-NMR; 0.7-1. 1 (t,
3H), 1. 6-2. 1 (m, 6H)
, 2. 2 ~2. 7 (m, 2H),
3. Spit. 2(m, 14H),? ..
s~7. 5 (m. 20H)'#204 mg of dimethylphosphinothioate compound synthesized in Example 1
(0.32 mmol), 3C-cholestanol 1
Suspend 26 mg (0.32 mmol), 1 mg (0.032 mmol) of trityl perchlorate, and 1 ml of molecular sieves powder in 1 ml of benzene, stir at room temperature for 30 minutes until saturated, and add 5 ml of an aqueous sodium bicarbonate solution. The reaction was stopped. The reaction mixture was filtered and extracted with dichloromethane, the organic layer was dried over anhydrous Fare! I sodium, the solvent was distilled off under reduced pressure, and preparative silica gel thin layer chromatography (Jilm agent; hexane: acetic acid) ethyl = 4:1)
When purified with 167mg of the target glycosyl compound
(57%) obtained. 'H-NMR; 0. 2 ~2. 2 (
m, 46H), 3. CL~5. 1 (m.
16H), 7. 0 ~ 7, 6 (m, 20H
) Example 2 97 mg (0.115 mmol) of the dimethylphosphinothioate compound synthesized in Reference Example 2, 58 mg (0.15 mmol) of 3Q-nirestanol, 5 mg (0.01!5 mmol) of trityl perchlorate,
Molecular sieves powder was suspended in 1 ml of benzene, stirred at room temperature for 30 minutes, and dissolved in saturated hydrogen carbonate.Example 3 Dimethylphosphinothioate compound synthesized in Reference Example 2*78 mg (0.12 mmol). 3fi'-prestanol 47mg (0.12mmol)+
Trityl perchlorate 2.3 mg (0.006 mmol),
Molecular sieves powder is suspended in 1 ml of benzene, stirred at room temperature for 30 minutes, and 5 ml of saturated aqueous sodium bicarbonate solution is added to stop the reaction. Thereafter, the same treatment as in Example 1 was carried out to obtain 79 mg (71%) of a glycosyl compound. 'H-NMR is the same as in Example 2.

層を無水硫酸ナトリウムで乾燥して、溶媒を減圧留去し
igI製用シリカゲル渾層クロマト(眉間剤;ヘキサン
: 酢酸エチル=481)で精製したところ目的のグリ
コシル化合物が1 1 1mg (80%)得られた. ’H−NMR;    0.  2 〜2.  2 (
m.  49H).3.  1〜5.  2 (m, 
 158).   7.  0 〜7.5(m,20H
) 実施例4 参考例2で合成したジメチルホスフィノチオエート化合
物78mg (0.  1 2mmo I)、3(一コ
レスタノール38mg(0.  1mmol.)、ヘキ
サクロロアンチモン酸トリチル15mg(0.01mm
ol)、モレキュラーシーブス粉末をベンゼン1mlに
懸濁させ、30分問室t星で攪はんし飽和炭酸水素ナト
リウム水溶液5m lを加え反応を俸止する.反応混合
物をろ過後ジクロ口メタンで抽出し、有機層を簾水硫酸
ナトリウムで乾燥して、溶媒を減圧留去し調製用シリカ
ゲル薄層クロマト(71間剤: ヘキサン: 酢酸エチ
ル=4:  1)で精製したところ目的のグリコシル化
合物が46mg (43%)得られた. ’H−NMRは実施例2に同じ。
The layer was dried over anhydrous sodium sulfate, the solvent was distilled off under reduced pressure, and the mixture was purified with igI silica gel layer chromatography (glabella; hexane: ethyl acetate = 481), yielding 111 mg (80%) of the desired glycosyl compound. Obtained. 'H-NMR; 0. 2 ~2. 2 (
m. 49H). 3. 1-5. 2 (m,
158). 7. 0 ~ 7.5 (m, 20H
) Example 4 78 mg (0.12 mmol.) of the dimethylphosphinothioate compound synthesized in Reference Example 2, 38 mg (0.1 mmol.) of monocholestanol, 15 mg (0.01 mmol.
ol), suspend the molecular sieves powder in 1 ml of benzene, stir for 30 minutes in a mixing chamber, and then add 5 ml of a saturated aqueous sodium bicarbonate solution to stop the reaction. The reaction mixture was filtered and extracted with dichloromethane, the organic layer was dried over aqueous sodium sulfate, the solvent was distilled off under reduced pressure, and preparative silica gel thin layer chromatography (71 mixture: hexane: ethyl acetate = 4: 1) was carried out. When purified, 46 mg (43%) of the desired glycosyl compound was obtained. 'H-NMR is the same as in Example 2.

実施例6 参考例1で合成したジメチルホスフィノチオエート化合
物67mg (0.  lmmo 1)、319一コレ
スタノール38mg (o.  lmmo +)+テト
ラフルオ口ホウ酸トリチル3mg(0.01mmol)
+  モレキュラーシーブス粉末をベンゼン1mlに懸
濁させ、30分問室温で攪はんし飽和炭酸水素ナトリウ
ム水溶液5mlを加え反応を停止する.反応混合物をろ
過後塩化メチレンで抽出し、膚機層を無水硫酸ナトリウ
ムで乾燥して、溶媒を減圧留去し調整用シリカゲル薄層
クロマト(雇間剤: ヘキサン: 酢酸エチル=4:1
)で精製したところ目的のグリコシド化合物が33mg
(34%)得られた. ’H−NMRは実施例2に同じ. 実施例6 参考例1で合成したジメチルホスフィノチオエート化合
$67mg(0.  1mmol)、3p−コレスタノ
ール3Bmg (0.  1mmo l)、5塩化スズ
トリチル5mg (0.O lmmo l)、モレキュ
ラーシーブス粉末をベンゼンlmlに懸濁させ、30分
ff!室温で攪はん(ノ飽和炭酸水素ナトリウム水溶液
5mlを加え反姿を停止する。反応混合物をろ過後ジク
ロロメタンで抽出し、壱機層を無水硫酸ナトリウムで乾
燥して、溶媒を減圧留去し調製用シリカゲル薄層クロマ
ト(展開剤;ヘキサン: 酢酸エチル=4+1)で精製
したところ目的のグリコシル化合物が41mg(43%
)得られた。
Example 6 67 mg (0. lmmo 1) of the dimethylphosphinothioate compound synthesized in Reference Example 1, 38 mg (o. lmmo +) of 319-cholestanol + 3 mg (0.01 mmol) of trityl tetrafluoroborate
+ Suspend the molecular sieves powder in 1 ml of benzene, stir at room temperature for 30 minutes, and add 5 ml of saturated aqueous sodium bicarbonate solution to stop the reaction. The reaction mixture was filtered and extracted with methylene chloride, the skin layer was dried over anhydrous sodium sulfate, the solvent was distilled off under reduced pressure, and the mixture was subjected to thin layer chromatography on silica gel for preparation (hexane: ethyl acetate = 4:1).
), the target glycoside compound was 33 mg.
(34%) was obtained. 'H-NMR was the same as in Example 2. Example 6 Dimethylphosphinothioate compound synthesized in Reference Example 1 $67 mg (0.1 mmol), 3p-cholestanol 3Bmg (0.1 mmol), tin trityl pentachloride 5 mg (0.0 mmol), molecular sieves powder Suspend it in 1 ml of benzene and leave it for 30 minutes ff! Stir at room temperature (5 ml of saturated aqueous sodium bicarbonate solution is added to stop the reaction. The reaction mixture is filtered, extracted with dichloromethane, the first layer is dried over anhydrous sodium sulfate, and the solvent is distilled off under reduced pressure. Purification using silica gel thin layer chromatography (developing agent: hexane: ethyl acetate = 4+1) yielded 41 mg (43%) of the desired glycosyl compound.
) obtained.

’ H − N M Rは実施例2に同じ。'H-NMR is the same as in Example 2.

実施例7 実施例8 参考例3で合成したジメチルホスフィノチオエート化合
!88mg (0.  1 3mmo l)、3Cーコ
レスタノール5 1 mg (0.  1 3mmo 
l)、過塩素酸トリチル4mg (0.  0 1mm
o l)、モレキュラーシーブス粉末をベンゼンlml
に懸濁させ、30分間室温で攪はんし飽和炭酸水業ナト
リウム水溶液5mlを加え反応を停止する.反応混合物
をろ過後ジクロ口メタンで抽出し、有機層を無水硫酸ナ
トリウムで乾燥して、溶媒を減圧留去し調製用シリカゲ
ル薄層クロマト(展開剤;ヘキサン: 酢酸エチル=4
:1)で精躾したところ目的のグリコシル化合物が49
mg (39%)得られた. H−NMR;    0.  2 〜2.   2  
(m,  5  1  1{).3.  3 〜5. 
 1(m,  115H),   .7.  0 〜?
.i5(m,20H) 参考例2で合成したジメチルホスフイノチオエート化合
物84mg(0.  13mmol)、 (1)一メン
トール20mg (0.  1 3mmo l)、過塩
素酸トリチル4.  5mg (0.  0 1 3m
mo +)、モレキュラーシーブス粉末をベンゼンlm
lに!millさせ、30分問室温で攪はんし飽和炭酸
水素ナトリウム水溶液5mlを加え反応を停止する.反
応混合物をろ過後ジクロ口メタンで抽出し、有機層を無
水硫酸ナトリウムで乾燥して、溶媒を減圧留去し調製用
シリカゲル薄層クロマト(屋間剤;ヘキサン: 酢酸エ
チル=4:1)で精製したところ目的のグリコシル化合
物が4 8mg (5 3%)得られた. ’H−NMR;   0.  6 〜1.  8 (m
,  18H).2.  0〜2.  6 (m,  
3H),  3.  1 〜5.  1 (m,  1
5H),  8.  9 〜7.  4(m.  20
H)寅施例9 H−NMR;    1.   2 〜 1.   6
(m,   15H).3.   1  〜5.   
1  (m,   20H),   5.   4 〜
15.   6( d,   11{),   7. 
  0  〜7.   5(m,   20H)実施例
l0 参考例2で合成したジメチルホスフィノチオエート化合
物84mg (0.  1 3mmo l)、 1.2
−3.4−ジー0−イソブロビリデンーD−ガラクトー
ス34mg (0.  1 3mmo +)、過塩素酸
トリチル4mg (0.0 1 3mmo l)、モレ
キュラーシーブス粉末をベンゼンImlに!!濁させ、
30分間室温で攪はんし飽和炭酸水素ナトリウム水溶液
5mlを加え反応を俸止する.反応混合物をろ過後ジク
ロ口メタンで抽出し、有機層を無水硫酸ナトリウムで乾
燥して、溶媒を減圧留去しv4ia用シリカゲル薄層ク
ロマト(展開剤; ヘキサン: 詐酸エチル=4:1)
で精製したところ目的のグリコシル化合物が84mg(
81%)得られた. 参考例2で合成したジメチルホスフィノチオエート化合
IJ78mg (0.  1 2mmo l)、n−オ
クタノール1 6mg (0.  1 2mmo l)
、過塩素酸トリチル4mg (0、0 1 3mmo 
l)、モレキュラーシーブス粉末をベンゼンlmlに懸
濁させ、30分閏室温で攪はんし飽和炭酸水素ナトリウ
ム水溶液5mlを加え反応を停止する.反応混合物をろ
過後ジクロ口メタンで抽出し、冑機層を無水硫酸ナトリ
ウムで乾燥して、溶媒を減圧留去し調製用シリカゲル薄
層クロマト(屓閏剤;ヘキサン: 詐酸エチル=4:1
)で精製したところ目的のグリコシル化合物が66mg
(82%)得られた. ’}l−NMR; O. 1・ (m. l 8 H). 3. 2 〜 6. (【n, 6 H ), 7. 〜 7. ( ml 2 0 H)
Example 7 Example 8 Dimethylphosphinothioate compound synthesized in Reference Example 3! 88 mg (0.13 mmol), 3C-cholestanol 51 mg (0.13 mmol)
l), trityl perchlorate 4mg (0.01mm
o l), add molecular sieves powder to lml of benzene
The mixture was suspended in water, stirred at room temperature for 30 minutes, and 5 ml of a saturated aqueous sodium carbonate solution was added to stop the reaction. The reaction mixture was filtered and extracted with dichloromethane, the organic layer was dried over anhydrous sodium sulfate, the solvent was distilled off under reduced pressure, and the mixture was subjected to preparative silica gel thin layer chromatography (developing agent: hexane: ethyl acetate = 4).
:1) After thorough training, the target glycosyl compound was 49
mg (39%) was obtained. H-NMR; 0. 2 ~2. 2
(m, 5 1 1{). 3. 3-5.
1 (m, 115H), . 7. 0 ~?
.. i5 (m, 20H) 84 mg (0.13 mmol) of the dimethylphosphinothioate compound synthesized in Reference Example 2, (1) 20 mg (0.13 mmol) of mono-menthol, 4. 5mg (0.013m
mo +), molecular sieves powder with benzene lm
To l! The mixture was stirred at room temperature for 30 minutes, and 5 ml of a saturated aqueous sodium bicarbonate solution was added to stop the reaction. The reaction mixture was filtered and extracted with dichloromethane, the organic layer was dried over anhydrous sodium sulfate, the solvent was distilled off under reduced pressure, and the mixture was purified using preparative silica gel thin layer chromatography (indoor solution; hexane: ethyl acetate = 4:1). After purification, 48 mg (53%) of the desired glycosyl compound was obtained. 'H-NMR; 0. 6 ~1. 8 (m
, 18H). 2. 0-2. 6 (m,
3H), 3. 1 to 5. 1 (m, 1
5H), 8. 9-7. 4 (m. 20
H) Tiger Example 9 H-NMR; 1. 2 ~ 1. 6
(m, 15H). 3. 1 to 5.
1 (m, 20H), 5. 4 ~
15. 6(d, 11{), 7.
0 to 7. 5 (m, 20H) Example 10 Dimethylphosphinothioate compound synthesized in Reference Example 2 84 mg (0.13 mmol), 1.2
-3.4-di-0-isobropylidene-D-galactose 34 mg (0.13 mmol +), trityl perchlorate 4 mg (0.013 mmol), molecular sieves powder in benzene Iml! ! Make it muddy,
Stir at room temperature for 30 minutes, then add 5 ml of saturated aqueous sodium hydrogen carbonate solution to stop the reaction. The reaction mixture was filtered and extracted with dichloromethane, the organic layer was dried over anhydrous sodium sulfate, the solvent was distilled off under reduced pressure, and the mixture was subjected to V4IA silica gel thin layer chromatography (developing agent: hexane: ethyl sulfate = 4:1).
The target glycosyl compound was 84 mg (
81%) was obtained. Dimethylphosphinothioate compound IJ synthesized in Reference Example 2 78 mg (0.12 mmol), n-octanol 16 mg (0.12 mmol)
, trityl perchlorate 4 mg (0,0 1 3 mmo
l) Suspend the molecular sieves powder in 1 ml of benzene, stir for 30 minutes at leap room temperature, and add 5 ml of saturated aqueous sodium bicarbonate solution to stop the reaction. The reaction mixture was filtered and extracted with dichloromethane, the aqueous layer was dried over anhydrous sodium sulfate, the solvent was distilled off under reduced pressure, and the mixture was subjected to preparative silica gel thin layer chromatography (hexanes: ethyl sulfate = 4:1).
), the target glycosyl compound was 66 mg.
(82%) obtained. '}l-NMR; O. 1. (ml 8 H). 3. 2 to 6. ([n, 6 H), 7. ~7. (ml20H)

Claims (1)

【特許請求の範囲】 1、ケトースのアノメリツク位がケタール結合している
糖の水酸基の水素が一般式 ▲数式、化学式、表等があります▼ (式中R^1、R^2は非置換または置換されたアルキ
ル基あるいはアリール基を示す。)で表されるホスフィ
ノチオイル基で置換されたケトースのアノメリック位チ
オホスフィン酸エステル誘導体と、脂肪族アルコール、
芳香族アルコール、ステロイドアルコール、グリセロー
ル誘導体、糖誘導体、アミノ酸誘導体から選ばれるアル
コールとをトリチル塩を共存させ反応させることを特徴
とするケトースのグリコシド系化合物の製造法。 2、ケトースのアノメリック位チオホスフィン酸エステ
ルとしてジメチルチオホスフィン酸エステル誘導体を用
いることを特徴とする特許請求の範囲第1項記載の製造
法。 3、トリチル塩として触媒量の過塩素酸トリチルを用い
ることを特徴とする特許請求の範囲第1項記載の製造法
[Scope of Claims] 1. The hydrogen of the hydroxyl group of the sugar in which the anomeric position of the ketose is ketal bonded has the general formula ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ (In the formula, R^1 and R^2 are unsubstituted or An anomeric thiophosphinic acid ester derivative of a ketose substituted with a phosphinothioyl group represented by (representing a substituted alkyl group or aryl group), an aliphatic alcohol,
A method for producing a ketose glycoside compound, which comprises reacting an alcohol selected from aromatic alcohols, steroid alcohols, glycerol derivatives, sugar derivatives, and amino acid derivatives in the presence of a trityl salt. 2. The production method according to claim 1, characterized in that a dimethylthiophosphinic acid ester derivative is used as the anomeric thiophosphinic acid ester of ketose. 3. The manufacturing method according to claim 1, characterized in that a catalytic amount of trityl perchlorate is used as the trityl salt.
JP6015089A 1989-03-13 1989-03-13 Method for producing glycoside compound of ketose Expired - Lifetime JPH0653754B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP6015089A JPH0653754B2 (en) 1989-03-13 1989-03-13 Method for producing glycoside compound of ketose

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6015089A JPH0653754B2 (en) 1989-03-13 1989-03-13 Method for producing glycoside compound of ketose

Publications (2)

Publication Number Publication Date
JPH02240093A true JPH02240093A (en) 1990-09-25
JPH0653754B2 JPH0653754B2 (en) 1994-07-20

Family

ID=13133838

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6015089A Expired - Lifetime JPH0653754B2 (en) 1989-03-13 1989-03-13 Method for producing glycoside compound of ketose

Country Status (1)

Country Link
JP (1) JPH0653754B2 (en)

Also Published As

Publication number Publication date
JPH0653754B2 (en) 1994-07-20

Similar Documents

Publication Publication Date Title
JP2751385B2 (en) Process for producing erythromycin A oxime and its salt
US5112994A (en) Method of producing (S)-4-hydroxymethyl-γ-lactone
JPH01180894A (en) Novel production of amino sugar derivative
JPS6215057B2 (en)
US7368593B1 (en) Method of selective esterification
JPH0768163B2 (en) Process for producing cyclopentenone derivative
JPH06508107A (en) New and improved solvent-free synthesis method of etheric substituted protected monosaccharides and their selective hydrolysis
US2659733A (en) Process of producing butyrolactones
JPH0653754B2 (en) Method for producing glycoside compound of ketose
TW301653B (en)
JP2001081097A (en) Hinokition acetoglucoside and its production
JPS61176564A (en) Production of 4-hydroxy-2-pyrrolidone
JPH0610164B2 (en) Isoprenyl benzoate derivative and process for producing the same
JPS61282390A (en) S-neuraminic acid derivative
JPS61243096A (en) Sialic acid derivative and production thereof
JPH03264576A (en) Production of aryl c-glycoside-based compound of aldose
JPS6219598A (en) 2,3,2&#39;3&#39;-tetra-o-alkyl-alpha,alpha-trehalose derivative
JPH0699460B2 (en) Process for producing 2-deoxy-aldose glycoside compound
JPH01100147A (en) Optically active malonic acid ester derivative
JP2023016443A (en) Method for production of 1,4-diacetoxy-2-methylnaphthalene
JPS63222192A (en) Novel ganglioside-related compound and production thereof
JPS61165348A (en) Production of carbenoxolone and disodium salt thereof
JPS6328074B2 (en)
JPH07116213B2 (en) Novel N-6,2&#39;-O-disubstituted-adenosine-3 &#39;, 5&#39;-cyclic phosphate and process for producing the same
JPH0460120B2 (en)